|
|
 |
|
Viewing report
|
|
|
|
Kosan Biosciences Inc.-Detailed Product Pipeline
Life Science Analytics, March 2008, Pages: 58
Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.
Scope of the reports
Each Pipeline Report provides the user with real detail on a company’s pipeline.
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company’s product pipeline and disease hub classification.
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company’s deals and alliances and recent corporate news including key milestones.
Key benefits
Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline.
Keep track of your competitors and partners by better understanding their product pipeline.
Monitor a company’s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.
Customers who bought this item also bought
Kosan Biosciences, Inc:Premium Company Profile
Digestive System - Gastroesophageal Reflux Disease Drug Pipeline Report
Digestive System Gastroesophageal Reflux Disease
Who's Developing What in New Cancer Drugs 2007?
Multiple Myeloma Therapeutics - US Market Trends & Analysis
Multiple Myeloma Therapeutics - US Market Trends & Analysis
Multiple Myeloma Therapeutics - Global Strategic Business Report
Stakeholder Opinions: Multiple Myeloma - Exploring new targets for multiple drug therapy
Innovative Targeted Therapies - Smart Drugs On Target For Increasing Growth
Late Stage Deals: Strategy, Structure and Payment Terms
Bristol-Myers Squibb Co.: PharmaVitae Profile
Cancer Therapies - Global Market Opportunities
|
|
|
|
